Show simple item record

Professor Advisordc.contributor.advisor
Authordc.contributor.authorOyarzún, Alejandra P. 
Authordc.contributor.authorWestermeier, Francisco 
Authordc.contributor.authorPennanen, Christian 
Authordc.contributor.authorLópez Crisosto, Camila 
Authordc.contributor.authorParra, Valentina 
Authordc.contributor.authorSotomayor Flores, Cristian 
Authordc.contributor.authorSánchez, Gina 
Authordc.contributor.authorPedrozo Cibils, Zully 
Authordc.contributor.authorTroncoso Cotal, Rodrigo 
Authordc.contributor.authorLavandero González, Sergio
Cita de ítemdc.identifier.citationBiochemical Pharmacology 98 (2015) 92–101en_US
Identifierdc.identifier.otherDOI: 10.1016/j.bcp.2015.08.097
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractAim: FK866 is an inhibitor of the NAD(+) synthesis rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). Using FK866 to target NAD(+) synthesis has been proposed as a treatment for inflammatory diseases and cancer. However, use of FK866 may pose cardiovascular risks, as NAMPT expression is decreased in various cardiomyopathies, with low NAD(+) levels playing an important role in cardiovascular disease progression. In addition, low NAD(+) levels are associated with cardiovascular risk conditions such as aging, dyslipidemia, and type II diabetes mellitus. The aim of this work was to study the effects of FK866-induced NAD(+) depletion on mitochondrial metabolism and adaptive stress responses in cardiomyocytes. Methods and results: FK866 was used to deplete NAD(+) levels in cultured rat cardiomyocytes. Cell viability, mitochondrial metabolism, and adaptive responses to insulin, norepinephrine, and H2O2 were assessed in cardiomyocytes. The drop in NAD(+) induced by FK866 decreased mitochondrial metabolism without changing cell viability. Insulin-stimulated Akt phosphorylation, glucose uptake, and H2O2-survival were compromised by FK866. Glycolytic gene transcription was increased, whereas cardiomyocyte hypertrophy induced by norepinephrine was prevented. Restoring NAD(+) levels via nicotinamide mononucleotide administration reestablished mitochondrial metabolism and adaptive stress responses. Conclusion: This work shows that FK866 compromises mitochondrial metabolism and the adaptive response of cardiomyocytes to norepinephrine, H2O2, and insulin.en_US
Patrocinadordc.description.sponsorshipFONDECYT 1120212 11130285 3130749 3140532 1130407 CONICYT Anillo ACT 1111 FONDAP 15130011 Red 120003en_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.uri*
Keywordsdc.subjectAdaptive responseen_US
Títulodc.titleFK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytesen_US
Document typedc.typeArtículo de revista

Files in this item


This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile